Attention-deficit/hyperactivity disorder (ADHD) has a strong genetic basis, and evidence from human and animal studies suggests the dopamine receptor D1 gene, DRD1, to be a good candidate for involvement. Here, we tested for linkage of DRD1 to ADHD by examining the inheritance of four biallelic DRD1 polymorphisms [D1P.5 (-1251HaeIII), D1P.6 (À800HaeIII), D1.1 (À48DdeI) and D1.7 ( þ 1403Bsp1286I)] in a sample of 156 ADHD families. Owing to linkage disequilibrium between alleles at the four markers, only three haplotypes are common in our sample. Using the transmission/disequilibrium test (TDT), we observed a strong bias for transmission of Haplotype 3 (1.1.1.2) from heterozygous parents to their affected children (P¼0.008). Furthermore, using quantitative trait TDT analyses, we found significant and positive relationships between Haplotype 3 transmission and the inattentive symptoms, but not the hyperactive/impulsive symptoms, of ADHD. These findings support the proposed involvement of DRD1 in ADHD, and implicate Haplotype 3, in particular, as containing a potential risk factor for the inattentive symptom dimension of the disorder. Since none of the four marker alleles comprising Haplotype 3 is predicted to alter DRD1 function, we hypothesize that a functional DRD1 variant, conferring susceptibility to ADHD, is on this haplotype. To search for such a variant we screened the DRD1 coding region, by sequencing, focusing on the children who showed preferential transmission of Haplotype 3. DNA from 41 children was analysed, and no sequence variations were identified, indicating that the putative DRD1 risk variant for ADHD resides outside of the coding region of the gene.
Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a childhood-onset disorder characterized by age-inappropriate and impairing levels of inattention (eg distractibility), hyperactivity (eg motor restlessness) and impulsivity. Family, twin and adoption studies have provided evidence for a genetic basis for ADHD, [1] [2] [3] and several twin studies have estimated the heritability of ADHD to be as high as 80-90%. [4] [5] [6] [7] [8] Although the aetiology of this disorder is currently unknown, genes of the dopamine neurotransmitter system are considered likely to be involved, since pharmacologic agents effective in the treatment of ADHD (ie methylphenidate and D-amphetamine) primarily influence the dopamine system. 9, 10 Support for genetic changes in dopamine neurotransmission in ADHD is found in positive and replicated linkage and/or association findings for the dopamine receptor D4, dopamine receptor D5 and dopamine transporter genes. 3, 11, 12 However, the relative risk associated with these genes appears to be quite low, and thus, additional genes are expected to be involved. Dopamine receptor D1 (designated D 1A in rodents) is the founding member of the D1 subfamily of dopamine receptors-receptors that mediate adenylyl cyclase activation and phosphoinositide hydrolysis via coupling to heterotrimeric G proteins, Gs and Gq, respectively. 13, 14 D1 receptors are prevalent in brain regions such as the prefrontal cortex (PFC) and striatum, and can also be found elsewhere in the body, such as in the kidney. 15, 16 On the basis of collective evidence from both animal and human studies (described below), the dopamine receptor D1 gene, DRD1, is a strong candidate for involvement in ADHD.
Dysfunction of the PFC is considered, by many, to be a fundamental problem in ADHD. This view stems from the observation that individuals with PFC lesions exhibit ADHD-like behaviour, 17, 18 and is supported by numerous neuropsychological and imaging studies showing evidence of compromised PFC function in individuals with ADHD. [18] [19] [20] The PFC guides behaviour, in part, through working memory, a cognitive process that is modulated by D1 receptors in this brain region. 21, 22 Interestingly, there have been several reports of working memory impairment in individuals with ADHD, 19, 23 and correlations between working memory capacity and attentional ability have been observed in individuals from the general population.
24, 25 Together, these studies suggest a relationship between the DRD1 gene and the attentional problems of children with ADHD.
Another line of evidence implicating DRD1 in the aetiology of ADHD is the hyperactive phenotype of D 1A -knockout mice. First, mice lacking the D 1A receptor exhibit locomotor hyperactivity. [26] [27] [28] However, not all studies have found this to be the case, [29] [30] [31] and thus it is thought that this hyperactive phenotype might be influenced by additional factors, such as variations in mouse genetic background and/or differences in methodologies used to assess locomotion. D 1A -knockout mice are also hyperactive in their grooming behaviour, 26 and this grooming behaviour is highly disorganized, in that these mice are unable to properly coordinate the entire sequence of movements that make up full grooming syntax. 32 Finally, although there have been several reports of reduced rearing activity in D 1A -knockout mice, 26, 29, 30 a detailed analysis of this behaviour has shown that only rearing free in a standing position, but not rearing against a wall or in a sitting position, is reduced in the mutant animals. 26 In fact, whereas during the initial observation period, rearing against a wall was found to be similar between wild type and D 1A -knockout mice, this rearing activity later subsided completely in the wild types, but persisted in the knockouts, further characterizing these mice as hyperactive. 26 Thus, the reductions in rearing behaviour that have been reported for D 1A -knockout mice are probably not due to reduced motor activity per se, but might instead be reflective of poor motor coordination (resulting in a reduced ability to carry out a difficult movement such as rearing free). That these mice also perform very poorly on the rotarod task, 29 a direct test of motor coordination, supports this view. Although murine correlates of ADHD behavioural symptoms are not well-defined, the combination of hyperactivity and impaired motor coordination that is evident in D 1A -knockout mice is intriguing, as several studies have reported deficits in motor coordination to be prevalent in children with ADHD. 33, 34 Finally, evidence from two rat models of ADHD implicates DRD1 in the aetiology of this disorder. The first is the Spontaneously Hypertensive rat (SHR). In addition to being studied as an animal model of hypertension, the SHR is considered to be a useful model of ADHD, prior to hypertension onset. 35 Although the mechanistic basis for the ADHD-like behaviour of the SHR remains to be elucidated, aberrant brain dopaminergic function has been strongly implicated. 36, 37 It is notable, therefore, that the development of hypertension in the SHR is due, at least in part, to a genetic defect in renal D 1A signaling. 38, 39 This suggests the interesting possibility that such a defect in D 1A signal transduction might also exist in the brain, thereby contributing to the ADHD-like behaviour of the SHR. Consistent with such a scenario, breeding studies have provided evidence that a component of the behavioural profile of the SHR cosegegrates with the D 1A signalling defect. 40 A second rat strain considered to be a useful behavioural model of ADHD is the Naples High Excitability (NHE) rat. 41 In a recent study it was shown that D 1A expression in the PFC is abnormally low in the NHE rat. 41 On the basis of evidence described above, we hypothesize that the DRD1 gene is involved in genetic susceptibility to ADHD. To test this hypothesis, we have examined the inheritance patterns of four DRD1 polymorphisms in a sample of 156 nuclear ADHD families, using both categorical and quantitative trait applications of the transmission/disequilibrium test (TDT).
Materials and methods

Subjects
Subject assessment and diagnostic criteria for inclusion in this study have been described previously. 42 Briefly, all of the children were between 7 and 16 years of age and met the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) 43 criteria for ADHD. Children who scored below 80 on both the Performance and Verbal Scales of the WISC-III (Weschsler Intelligence Scale for Children, 3rd Edition) 44 were excluded from the study, as were children who exhibited neurological or chronic medical illness, Tourette syndrome, chronic multiple tics, bipolar affective disorder, psychotic symptoms or other anxiety, depressive or developmental disorder that might better account for their behaviour. Children with a family history of bipolar disorder or schizophrenia were also excluded from the analysis. Diagnoses of ADHD and comorbid conditions were based on information obtained from semistructured interviews of parents (Parent Interview for Child Symptoms) 45 and teachers (Teacher Telephone Interview for Children's Academic Performance, Attention, Behaviour and Learning: DSM-IV Version), 46 and from the following standardized questionnaires and assessments: Conners Parent and Teacher Rating Scales-Revised, 47 Ontario Child Health Survey Scales-Revised, 48 Wide Range Achievement TestRevision 3, 49 Clinical Evaluation of Language Fundamentals-3rd Edition, 50 Children's Depression Inventory 51 and Children's Manifest Anxiety Scale. 52 Children were free of medication for at least 24 h Dopamine receptor D1 and ADHD VL Misener et al prior to assessment. Among the children included in this study, 82% were boys and 18% girls, and the distribution of ADHD subtypes is as follows: 25% Predominantly Inattentive Type, 18% Predominantly Hyperactive/Impulsive Type, 57% Combined Type. The assignment of subtypes, as recognized by the DSM-IV 43 , was based on scores for the inattentive and hyperactive/impulsive symptom dimensions of ADHD, as reported in the interviews with parents and teachers (see above). This study protocol was approved by the Hospital for Sick Children Research Ethics Board, with written informed consent obtained for all participants.
Isolation of DNA and genotyping of markers DNA was extracted from peripheral blood using a high-salt extraction method. 53 Genotypes for each of four DRD1 markers were determined by PCR amplification of 60-100 ng DNA, followed by restriction enzyme digestion of the PCR products. Four primer pairs, designated 5
0 -D1/3 0 -D1.D and 5 0 -D1.7/3 0 -D1.9, were used for amplification of the D1P.5, D1P.6, D1.1 and D1.7 markers, respectively. 54, 55 Primer sequences are given in Table 1 . PCR reactions (20 ml volume) supplemented with 1.5 mM MgCl 2 (for D1P.6, D1.1 and D1.7) or with 1.5 mM MgSO 4 plus 4 ml Betaine (Sigma-Aldrich Canada Inc., Oakville, Ontario, Canada) (for D1P.5) were carried out as follows: (1) initial denaturation (4 min at 941C), (2) 35 cycles of: denaturation (40 s at 941C), annealing (40 s at 571C) and extension (30 s at 721C), and (3) final extension (10 min at 721C). For genotyping, 7.5 ml of the D1P.5 amplification product was digested with 5 U HaeIII, 7.5 ml of the D1P.6 product was digested with 10 U HaeIII, 8 ml of the D1.1 product was digested with 5 U DdeI, and 5 ml of the D1.7 product was digested with 7.5 U Bsp1286I (restriction enzymes from New England Biolabs, Beverly, MA, USA). For the D1P.5, D1P.6 and D1.7 markers, restriction fragments were resolved on agarose gels consisting of 1.8% agarose plus 1.8% NuSieve 3:1 agarose (Mandel Scientific Company, Inc., Guelph, Ontario, Canada), and visualized by ethidium bromide staining. For the D1.1 marker, fragments were resolved on 10% polyacrylamide gels and visualized by silver staining.
Statistical analysis
The degree of linkage disequilibrium (pairwise association) between marker alleles in this study was evaluated according to Lewontin, 56, 57 expressing the coefficient of linkage disequilibrium as D 0 . Parental allele frequencies and 2-marker haplotype frequencies, used in the calculation of D 0 , were determined using the Estimate Haplotypes (EH) program. 58 TDT analyses, considering ADHD diagnosis as a categorical trait, were carried out using the extended TDT (ETDT) program 59 to examine the transmission of individual marker alleles, and the TRANSMIT program 60 to examine the transmission of haplotypes. For biallelic markers (as in this study), the ETDT 61 In the analysis of haplotypes, however, the TRANSMIT program makes maximal use of the sample via a likelihood approach that estimates missing information. This allows families with missing parents, as well as families for which haplotype phase is uncertain, to be included in the analysis without bias. 60, 62 Quantitative trait TDT analyses, examining transmission of Haplotype 3 in relation to DSM-IV symptom scores, were carried out using the FBAT program (v1.4.1) 63, 64 and a logistic regression-based extension of the TDT 65 , both of which are robust to potentially biasing effects of non-normality in the phenotype distribution. The test statistic calculated in FBAT is essentially the covariance between haplotype transmission and the offspring phenotype (symptom score). The FBAT program allows for the inclusion of some single-parent families for which genotypes of more than one offspring are available. The logistic regression-based TDT method uses standard logistic regression analysis to model the probability of transmission of a particular allele from heterozygous parents to their offspring as a function of the offspring phenotype score. As with ETDT (see above), families with a missing parent were excluded from the logistic regression-based analysis. As this method does not support the analysis of haplotypes, Allele 1 of the D1P.6 marker was used as a proxy for Haplotype 3. This was an arbitrary choice among three alleles (D1P.6 Allele 1, D1.1 Allele 1 and D1.7 Allele 2) that are found almost exclusively within Haplotype 3 in our sample (see Table 4 ). As described elsewhere, 65 transmissions from heterozygous parents were assigned a binary variable of either '1' (for transmission of D1P.6 Allele 1) or '0' (for nontransmission of the allele) and logistic regression analysis, using SPSS software (SPSS Inc., Chicago, IL, USA), was carried out to test the relationship between this variable and the offspring phenotype scores. For both the FBAT and logistic regression analyses, the quantitative phenotypes of inattentive and hyperactive/impulsive symptom counts (of a possible nine for each dimension, as specified by the DSM-IV 43 ) were tallied for parents and teachers separately. In our study sample, parent-reported symptom scores ranged from 0 to 9 (mean¼6.6672.04) for inattentive behaviour and from 0 to 9 (mean¼6.5072.26) for hyperactive/ impulsive behaviour, and the corresponding teacherreported scores ranged from 0 to 9 (mean¼6.3572.08) and from 0 to 9 (mean¼5.4172.64), respectively. All P-values in this study are reported without correction for multiple testing.
DNA Sequence Analysis
Sequence analysis of the DRD1 gene was carried out by direct sequencing of four PCR products, designated D1Seq1, D1Seq2, D1Seq3 and D1Seq4. Each was amplified from 60-100 ng of genomic DNA (purified as above), using primer pairs listed in Table 2 . PCR reactions (20 ml volume) supplemented with 1.5 mM MgCl 2 (for D1Seq3 and D1Seq4) or with 1.5 mM MgSO 4 plus 4 ml Betaine (Sigma-Aldrich Canada Inc., Oakville, Ontario, Canada) (for D1Seq1 and D1Seq2) were carried out as follows: (1) initial denaturation (4 min at 941C); (2) 35 cycles of: denaturation (40 s at 941C), annealing (40 s at the appropriate temperature listed in Table 2 ) and extension (30 s at 721C); and (3) final extension (10 min at 721C). PCR products (5 ml) were treated with Exonuclease I and Shrimp Alkaline Phosphatase (PCR Product Pre-sequencing Kit; USB Corporation, Cleveland, OH, USA) according to the manufacturer's instructions, and sequenced directly using either of the two primers that was used for PCR amplification. Fluorescent automated DNA sequencing was carried out using the ABI PRISM BigDye Terminator v3.0 Cycle Sequencing System (Applied Biosystems, Foster City, CA, USA) and Sequencher analysis software (Gene Codes Corporation, Ann Arbor, MI, USA).
Results
In this study, 156 nuclear families ascertained through an ADHD proband were analysed. The sample consists of 123 families in which both parents The four polymorphic DRD1 markers analysed, D1P.5, D1P.6, D1.1 and D1.7, are described in Table 1 . Also shown are the allele frequencies for these markers, as determined from the 558 parental chromosomes in our study. All of the values obtained are similar to those which have been reported previously by others. 54, 55 To evaluate the degree of association (ie linkage disequilibrium) between marker alleles, we employed the widely used method of Lewontin. 56, 57 Marker positions and the coefficient of linkage disequilibrium (D 0 ) for each marker pair are shown in Figure 1 . Consistent with the strong degree of linkage disequilibrium observed in each case, among the 16 haplotypes that are theoretically possible for these markers, only three (ie 1.2.2.1, 2.2.2.1 and 1.1.1.2) are common in our sample. Haplotype designations and the parental haplotype frequencies are shown in Table 4 .
To test for linkage of the DRD1 gene to ADHD we used the TDT, a family-based association method that is also a test of linkage in the presence of linkage disequilibrium. The TDT has been shown to be a valid test of linkage when the data are derived from families with one affected offspring, families with two or more affected offspring, or a mixture of the two types. [66] [67] [68] [69] Indeed, the inclusion of a substantial number of families with affected siblings (eg 23% in our study) may enhance the power of the TDT since, if phenocopies exist, an allele that predisposes to the disorder is more likely to be present in familial than in sporadic cases. 59 The TDT tests for biased transmission of marker alleles from heterozygous parents to their affected children. As shown in Table 3 , we found trends for biased allele transmission for each of the individual markers analysed (ie biased towards transmission of D1P.5 Allele 1, P¼0.180; D1P.6 Allele 1, P¼0.086; D1.1 Allele 1, P¼0.084; D1.7 Allele 2, P¼0.089). The similarities in these trends is not surprising given the strong linkage disequilibrium observed for each marker pair. As shown in Table 4 The DSM-IV diagnosis of ADHD 43 is based on symptom counts for the inattentive and hyperactive/ impulsive dimensions of the disorder, but there is 85 Hatched ovals represent two promoters (P1 and P2) from which the gene is expressed. 86 The hatched box represents an oestrogen response element (ERE) that upregulates expression from P1. 72 The four PCR products used for sequencing of the coding region are shown below the map. All nucleotide positions are numbered relative the first nucleotide ( þ 1) of the translational start codon (map not drawn to scale). considerable heterogeneity, with respect to both symptom type and number, among children diagnosed with ADHD. How this heterogeneity is related to genetic factors is not clear at present; however, twin studies indicate that both shared and unique genetic influences are likely to underlie the two behavioural dimensions. 8 On the basis of evidence reviewed in the Introduction, we hypothesized that DRD1 would be a risk factor for both inattentive and hyperactive behaviour. Thus, we predicted that within our sample of children diagnosed with ADHD, the bias for transmission of Haplotype 3 would be related to high symptom scores for both the inattentive and hyperactive/impulsive dimensions of the disorder. To test this, we performed quantitative trait TDT analysis to examine Haplotype 3 transmission in relation to DSM-IV inattentive and hyperactive/impulsive symptom counts ascertained through interviews with both parents and teachers. The results are shown in Tables  5 and 6 . Using the FBAT program 63, 64 we found significant and positive relationships between transmission of Haplotype 3 and inattentive symptom scores reported by both parents (P¼0.024) and teachers (P¼0.030). These relationships were confirmed using a logistic regression-based method 65 (P¼0.008 and 0.045, respectively), with odds ratios showing that for every increment of 1 in the parent-or teacher-reported symptom score, the odds of Haplotype 3 transmission increased B1.2-fold. In contrast to these results, no significant relationships between hyperactive/impulsive symptom scores and Haplotype 3 transmission were evident using either method of analysis. Thus, our quantitative trait TDT analyses showed significant evidence for linkage of Haplotype 3 to the inattentive symptoms, but not the hyperactive/impulsive symptoms, of ADHD.
Among the four marker alleles that make up Haplotype 3, none is predicted to alter DRD1 function. 70 As illustrated in Figure 1 , the D1.7 marker is located in the 3 0 -untranslated region 54 and D1P.6 and D1.1 are located in the 5 0 -untranslated region. 54, 55 The D1P.5 marker is located B0.2 kb upstream of one of two promoters for this gene, 55 but outside of regions identified as being important in the regulation of DRD1 transcription. 71, 72 Thus, we hypothesize that there is some functional DRD1 variant, on Haplotype 3, that confers susceptibility to ADHD. To identify such a variant, we have undertaken a screen of the DRD1 gene in our ADHD sample, beginning with the coding region. This 1341 bp region, which is contained within a single exon, was sequenced from four overlapping PCR products amplified from genomic DNA, as shown in Figure 1 . DNA from 41 children who showed preferential transmission of Haplotype 3 (12 homozygotes and 29 heterozygotes) was analysed. No DNA variants in the DRD1 coding region were identified, indicating that the putative DRD1 risk variant for ADHD resides outside of the coding region of the gene.
Discussion
In this study, we tested the DRD1 gene as a candidate for involvement in genetic susceptibility to ADHD, using a sample of 156 nuclear families ascertained through an ADHD proband. The families were genotyped for four polymorphic markers of the DRD1 gene, and TDT analyses were performed to test for linkage of DRD1 to the diagnosis of ADHD, and to the inattentive and hyperactive/impulsive symptom dimensions of the disorder. Significant evidence for linkage of DRD1 to ADHD was obtained using both approaches. In the TDT analysis in which ADHD diagnosis was considered as a categorical trait, strong evidence for biased transmission of Haplotype 3 from heterozyous parents to their ADHD-affected offspring was observed (P¼0.008). Although marginally significant evidence for nontransmission of Haplotype 2 (P¼0.045) was also observed, this result should be regarded cautiously as it is based on a considerably smaller number of informative transmissions. In the quantitative trait TDT analyses, in which Haplotype 3 transmission was analysed in relation to offspring symptom scores, we found significant evidence for linkage of Haplotype 3 to the inattentive symptoms, but not the hyperactive/impulsive symptoms, of ADHD. Previously, twin studies have shown that inattentive behaviour and hyperactive/impulsive behaviour are both highly heritable, 6, 8, [73] [74] [75] and that both shared and unique genetic influences are likely to underlie these two behavioural dimensions. 8 Although we cannot rule out the possibility of some involvement of the DRD1 gene in the hyperactive/ impulsive symptoms of ADHD, our data clearly implicate DRD1 Haplotype 3 as being involved in genetic risk for the inattentive dimension of the disorder.
The DRD1 gene was also analysed recently by others, as part of a survey of several dopamine system genes, in an ADHD sample of Irish origin. 76 In contrast to our findings, that study did not find evidence for linkage of DRD1 to the diagnosis of ADHD. Several factors might account for the different results obtained in the Irish study as compared to ours. For example, different ethnic compositions of the two study samples might be a factor. In contrast to the Irish study (in which families were 98% ethnically Irish), 76 most of the families in our study are of mixed European Caucasian descent. Only 40 families reported having an Irish ancestor, and among those, only one reported all four grandparents of the proband as being Irish. In addition to potential effects related to ethnic differences, the power to detect linkage in the Irish study may have been limited by the smaller sample size than that of our study (118 vs 196 ADHD-affected children, respectively), and/or by the analysis of only a single DRD1 marker, rather than of haplotypes. Finally, given the apparent involvement of DRD1 in genetic risk for the inattentive symptom dimension, in particular, it is possible that the difference in results obtained in the two studies is related to under-representation of the Primarily Inattentive ADHD subtype in the Irish sample (8%) 77 relative to ours (25%). It is worth noting here that while some studies have found a higher proportion of girls contributing to the Primarily Inattentive subtype Table 5 .
than to the Primarily Hyperactive/Impulsive or Combined subtype, 78, 79 this difference between the two samples is not reflective of differing gender ratios, as similar proportions of boys and girls are found in our sample (82% boys, 18% girls) and the Irish sample (86% boys, 14% girls). 77 Replication of our DRD1 linkage findings in other samples of ADHD families will be important in the future.
On the basis of our current findings, we predict that a functional DRD1 variant conferring susceptibility to ADHD is on Haplotype 3, the risk haplotype identified in our study. To search for such a variant, we conducted a DNA sequencing screen of the DRD1 gene in our sample, focusing on the children who showed preferential transmission of Haplotype 3. No DNA sequence variations were identified in our search of the coding region, a result which is consistent with previous SSCP-based analyses that found no evidence of DRD1 coding region changes in individuals with ADHD. 80, 81 To date, there have been no reports of similar screening applied to other regions of the gene. We are currently expanding our search to cover the entire DRD1 gene, including all elements of known regulatory function (see Figure 1 ).
In conclusion, the present study supports the hypothesized involvement of the DRD1 gene in susceptibility to ADHD, and suggests a relationship between Haplotype 3 and the inattentive symptom dimension, in particular. Given the possible relationship between attentional problems and working memory deficits in ADHD, and the known importance of D1 receptors in working memory function, an interesting line of enquiry in the future would be to investigate whether Haplotype 3 is also a risk factor for poor working memory ability in ADHD. Regardless of the biological mechanism(s) by which DRD1 might be involved in the disorder, it is notable that a recent ADHD genome scan suggested linkage to a region on chromosome 10 that harbours the gene for calcyon, 82 a transmembrane protein that binds to the D1 receptor and regulates D1-mediated signaling. 83, 84 Thus, we speculate that functional variation in the calcyon and DRD1 genes might constitute distinct, but related, genetic mechanisms leading to perturbations in D1 signalling that contribute to ADHD.
